Should I buy Morgan Stanley (MS) stock or is it too late?

Morgan Stanley · Financials · price $187

See the full Morgan Stanley (MS) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: HSBC — 77% of its targets hit on this sector (26 calls tested). It aims for $219 (+17 %), call made on September 29, 2026, maturing on September 29, 2027 (15 d ago).

The 10 reliable analysts $217+16 %

The 4 other firms $239+28 %

How to read it: the 10 reliable firms are not filtered by optimism — 10 aim above the price, 0 below, hence their $217 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Morgan Stanley

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
B of A Securities	92 %	+50.0 %	12	$250 +34%
Citigroup	88 %	+41.7 %	8	$210 +13%
UBS	75 %	+31.6 %	8	$236 +26%
Oppenheimer	77 %	+28.2 %	22	$105 -44%
JP Morgan	67 %	+27.1 %	6	$195 +4%
Evercore ISI Group	82 %	+26.5 %	11	$215 +15%
Barclays	83 %	+17.8 %	12	$262 +40%
BMO Capital	71 %	+13.7 %	14	$215 +15%

In short — Should you invest in Morgan Stanley? Is it too late, still worth it? Analysts are split (50% buy, median target $223, i.e. +19%), and the most reliable on MS targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $223, i.e. +19% from the current price ($187).
The most reliable firm on MS, HSBC (100% hit rate, 3 scored calls), targets $219 (call made on September 28, 2026, maturing on September 28, 2027) (+17%) in its most recent call, and $215 (call made on July 21, 2026, maturing on July 21, 2027) (+15%) in the one coming due soonest.
5 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.
Pays a dividend (1.9% yield), raised for 12 years — regular income on top of potential upside.
Reasonable valuation (P/E ~15) relative to its sector.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 14 ratings, 6 are neutral and 1 is a sell.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on MS

Median target $223 (+19%) · 14 ratings · Hold consensus

Strong Buy00%

Buy750%

Hold643%

Sell17%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Morgan Stanley now?

We won't decide for you. The facts: 50% of analysts rate it a buy, median target $223 (+19%), and HSBC (most reliable on MS, 100%) targets $219. Weigh that against valuation (P/E ~15). This is not personalized advice.

Is it too late to invest in Morgan Stanley?

Not according to analysts: the median target ($223) is still +19% above the current price ($187) (most reliable on MS: HSBC, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Morgan Stanley still worth investing in?

It depends on the gap between the price ($187) and its estimated value: analysts target $223 on median (+19%), with 50% buys (most reliable on MS: HSBC, 100%). Cross-check with their real reliability on MS and the cautions above. Information, not advice.

What's the main risk in buying MS?

The consensus is not unanimous: of 14 ratings, 6 are neutral and 1 is a sell.

→ Go deeper: the full Morgan Stanley profile (consensus, analyst reliability, price target, performance).